Skip to main content
Premium Trial:

Request an Annual Quote

IntelligentMDx Nets $3M Investment

NEW YORK (GenomeWeb News) – Cambridge, Mass.-based molecular diagnostics company IntelligentMDx has raised $3 million in a financing from two undisclosed investors, the company said on Tuesday.

The company will use the funds to develop tests for specific viral and bacterial nucleic acid targets using a proprietary bioinformatics approach. It makes molecular diagnostic test kits for transplantation, fungal infection, blood screening, meningitis/encephalitis, and respiratory disease.

The company said it raised the $3 million through a Series D preferred stock offering it began on May 12. IntelligentMDx also noted that it has raised a total of $26.5 million through funding from non-venture capital investors since 2004.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.